- $222.42m
- $359.08m
- $702.43m
- 67
- 73
- 45
- 65
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 826 | 754 | 834 | 938 | 702 |
Cost of Revenue | |||||
Gross Profit | 159 | 172 | 162 | 141 | 81 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 775 | 707 | 770 | 900 | 751 |
Operating Profit | 51.2 | 47.2 | 63.9 | 38.8 | -48.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 72 | -25 | 67.2 | 32.8 | -160 |
Provision for Income Taxes | |||||
Net Income After Taxes | 58.5 | -16.8 | 57.9 | 28.4 | -106 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 48.3 | -75.4 | 57.8 | 28.5 | -106 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 48.3 | -75.4 | 57.8 | 28.5 | -106 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.78 | -0.068 | 1.76 | 0.864 | -2.34 |
Dividends per Share | |||||
Special Dividends per Share |